Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1986 3
1987 4
1988 2
1990 5
1991 1
1992 3
1994 4
1995 3
1996 5
1997 2
1998 3
1999 9
2000 6
2001 1
2002 4
2003 4
2004 2
2005 7
2006 9
2007 6
2008 6
2009 11
2010 16
2011 14
2012 11
2013 20
2014 23
2015 12
2016 14
2017 17
2018 13
2019 19
2020 17
2021 16
2022 27
2023 13
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Özgüroğlu M, Ye D, Feyerabend S, Protheroe A, De Porre P, Kheoh T, Park YC, Todd MB, Chi KN; LATITUDE Investigators. Fizazi K, et al. N Engl J Med. 2017 Jul 27;377(4):352-360. doi: 10.1056/NEJMoa1704174. Epub 2017 Jun 4. N Engl J Med. 2017. PMID: 28578607 Free article. Clinical Trial.
[Prostate cancer].
Morote J, Maldonado X, Morales-Bárrera R; en nombre del grupo multidisciplinario para el estudio y tratamiento del cáncer de próstata Vall d’Hebron. Morote J, et al. Med Clin (Barc). 2016 Feb 5;146(3):121-7. doi: 10.1016/j.medcli.2014.12.021. Epub 2015 Feb 26. Med Clin (Barc). 2016. PMID: 25727526 Review. Spanish.
Systematic review of renal carcinoma prognostic factors.
Lorente D, Trilla E, Meseguer A, Planas J, Placer J, Celma A, Salvador C, Regis L, Morote J. Lorente D, et al. Among authors: morote j. Actas Urol Esp. 2017 May;41(4):215-225. doi: 10.1016/j.acuro.2016.08.003. Epub 2016 Sep 20. Actas Urol Esp. 2017. PMID: 27659130 Review. English, Spanish.
Bone health in patients with prostate cancer.
Miñana B, Cózar JM, Alcaraz A, Morote J, Gómez-Veiga FJ, Solsona E, Rodríguez-Antolín A, Carballido J. Miñana B, et al. Among authors: morote j. Actas Urol Esp. 2014 Dec;38(10):685-93. doi: 10.1016/j.acuro.2014.05.003. Epub 2014 Jun 14. Actas Urol Esp. 2014. PMID: 24934457 Review. English, Spanish.
The present and future of prostate cancer urine biomarkers.
Rigau M, Olivan M, Garcia M, Sequeiros T, Montes M, Colás E, Llauradó M, Planas J, Torres Id, Morote J, Cooper C, Reventós J, Clark J, Doll A. Rigau M, et al. Among authors: morote j. Int J Mol Sci. 2013 Jun 17;14(6):12620-49. doi: 10.3390/ijms140612620. Int J Mol Sci. 2013. PMID: 23774836 Free PMC article. Review.
Maximal testosterone suppression in prostate cancer--free vs total testosterone.
Rove KO, Crawford ED, Perachino M, Morote J, Klotz L, Lange PH, Andriole GL, Matsumoto AM, Taneja SS, Eisenberger MA, Reis LO. Rove KO, et al. Among authors: morote j. Urology. 2014 Jun;83(6):1217-22. doi: 10.1016/j.urology.2014.02.001. Epub 2014 Apr 6. Urology. 2014. PMID: 24713136 Free PMC article. Review.
288 results